These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 12744737)
21. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis. Gramantieri L; Chieco P; Di Tomaso M; Masi L; Piscaglia F; Brillanti S; Gaiani S; Valgimigli M; Mazziotti A; Bolondi L Clin Cancer Res; 1999 Nov; 5(11):3468-75. PubMed ID: 10589760 [TBL] [Abstract][Full Text] [Related]
22. Expression of aberrant functional and nonfunctional transcripts of the FHIT gene in Burkitt's lymphomas. Ferrer M; López-Borges S; Lazo PA Mol Carcinog; 1999 May; 25(1):55-63. PubMed ID: 10331745 [TBL] [Abstract][Full Text] [Related]
23. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines. Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495 [TBL] [Abstract][Full Text] [Related]
24. Decreased FHIT protein expression correlates with a worse prognosis in patients with diffuse large B-cell lymphoma. Chen PM; Yang MH; Hsiao LT; Yu IT; Chu CJ; Chao TC; Yen CC; Wang WS; Chiou TJ; Liu JH Oncol Rep; 2004 Feb; 11(2):349-56. PubMed ID: 14719066 [TBL] [Abstract][Full Text] [Related]
25. Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development. Lea JS; Ashfaq R; Muneer S; Burbee DG; Miller DS; Minna JD; Muller CY J Soc Gynecol Investig; 2004 Jul; 11(5):329-37. PubMed ID: 15219888 [TBL] [Abstract][Full Text] [Related]
26. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas. Lee SH; Kim WH; Kim HK; Woo KM; Nam HS; Kim HS; Kim JG; Cho MH Biochem Biophys Res Commun; 2001 Jun; 284(3):850-5. PubMed ID: 11396980 [TBL] [Abstract][Full Text] [Related]
27. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Negrini M; Monaco C; Vorechovsky I; Ohta M; Druck T; Baffa R; Huebner K; Croce CM Cancer Res; 1996 Jul; 56(14):3173-9. PubMed ID: 8764101 [TBL] [Abstract][Full Text] [Related]
28. Expression of the fragile histidine triad gene in normal rat tissues and human kidney cancer cell lines. Lee SH; Kim TJ; Kim HY; Kim JG; Park MK; Woo KM; Kim SH; Hwang KY; Nam HS; Min YK; Cho MH Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):145-57. PubMed ID: 15080505 [TBL] [Abstract][Full Text] [Related]
29. Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck. Kisielewski AE; Xiao GH; Liu SC; Klein-Szanto AJ; Novara M; Sina J; Bleicher K; Yeung RS; Goodrow TL Oncogene; 1998 Jul; 17(1):83-91. PubMed ID: 9671317 [TBL] [Abstract][Full Text] [Related]
30. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816 [TBL] [Abstract][Full Text] [Related]
31. Multiple molecular alterations of FHIT in betel-associated oral carcinoma. Chang KW; Kao SY; Tzeng RJ; Liu CJ; Cheng AJ; Yang SC; Wong YK; Lin SC J Pathol; 2002 Mar; 196(3):300-6. PubMed ID: 11857493 [TBL] [Abstract][Full Text] [Related]
32. [FHIT gene is abnormal in tongue carcinoma cell line]. Liu F; Wu J; Sun Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Sep; 20(3):472-5. PubMed ID: 14565016 [TBL] [Abstract][Full Text] [Related]
33. Abnormalities of the FHIT transcripts in osteosarcoma and Ewing sarcoma. Hinohara S; Satake N; Sekine K; Kaneko Y Jpn J Cancer Res; 1998 Sep; 89(9):887-94. PubMed ID: 9818023 [TBL] [Abstract][Full Text] [Related]
34. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma. Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242 [TBL] [Abstract][Full Text] [Related]
35. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours. Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528 [TBL] [Abstract][Full Text] [Related]
36. Pattern of FHIT gene expression in normal and leukaemic cells. Yang HW; Piao HY; Taki T; Chen T; Hashizume K; Ohnishi H; Bessho F; Yanagisawa M; Matsuo Y; Hayashi Y Int J Cancer; 1999 Jun; 81(6):897-901. PubMed ID: 10362136 [TBL] [Abstract][Full Text] [Related]
37. FHIT mutations in human primary gastric cancer. Gemma A; Hagiwara K; Ke Y; Burke LM; Khan MA; Nagashima M; Bennett WP; Harris CC Cancer Res; 1997 Apr; 57(8):1435-7. PubMed ID: 9108441 [TBL] [Abstract][Full Text] [Related]
38. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas. Bugert P; Wilhelm M; Kovacs G Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948 [TBL] [Abstract][Full Text] [Related]
39. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Tanaka H; Shimada Y; Harada H; Shinoda M; Hatooka S; Imamura M; Ishizaki K Cancer Res; 1998 Aug; 58(15):3429-34. PubMed ID: 9699676 [TBL] [Abstract][Full Text] [Related]
40. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation. Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]